Nutralife Biosciences Stock Earnings Per Share
| NLBS Stock | USD 0.0001 0.00 0.00% |
Nutralife Biosciences fundamentals help investors to digest information that contributes to Nutralife Biosciences' financial success or failures. It also enables traders to predict the movement of Nutralife Pink Sheet. The fundamental analysis module provides a way to measure Nutralife Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nutralife Biosciences pink sheet.
Nutralife |
Nutralife Biosciences Company Earnings Per Share Analysis
Nutralife Biosciences' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Nutralife Biosciences Earnings Per Share | (0.03) X |
Most of Nutralife Biosciences' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nutralife Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Nutralife Biosciences has an Earnings Per Share of -0.026 times. This is 100.31% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The earnings per share for all United States stocks is 100.83% higher than that of the company.
Nutralife Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nutralife Biosciences' direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nutralife Biosciences could also be used in its relative valuation, which is a method of valuing Nutralife Biosciences by comparing valuation metrics of similar companies.Nutralife Biosciences is currently under evaluation in earnings per share category among its peers.
Nutralife Fundamentals
| Return On Equity | -14.26 | |||
| Return On Asset | -0.28 | |||
| Operating Margin | (3.80) % | |||
| Current Valuation | 11.61 M | |||
| Shares Outstanding | 176.62 M | |||
| Shares Owned By Insiders | 45.95 % | |||
| Price To Book | 85.51 X | |||
| Price To Sales | 14.09 X | |||
| Revenue | 626.62 K | |||
| Gross Profit | 83.59 K | |||
| EBITDA | (5.71 M) | |||
| Net Income | (5.83 M) | |||
| Cash And Equivalents | 51.8 K | |||
| Total Debt | 10 K | |||
| Current Ratio | 0.10 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (487.39 K) | |||
| Earnings Per Share | (0.03) X | |||
| Number Of Employees | 12 | |||
| Beta | -0.9 | |||
| Market Capitalization | 6.62 M | |||
| Total Asset | 4.85 M | |||
| Net Asset | 4.85 M |
About Nutralife Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nutralife Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nutralife Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nutralife Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nutralife Pink Sheet Analysis
When running Nutralife Biosciences' price analysis, check to measure Nutralife Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutralife Biosciences is operating at the current time. Most of Nutralife Biosciences' value examination focuses on studying past and present price action to predict the probability of Nutralife Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutralife Biosciences' price. Additionally, you may evaluate how the addition of Nutralife Biosciences to your portfolios can decrease your overall portfolio volatility.